Psychostimulants are frequently abused as a result of their stimulatory effects on several neurotransmitter systems within the central nervous system. Both dopaminergic and glutaminergic neurotransmissions have been closely associated with psychostimulant dependence. In addition to its classical endocrine function in the periphery, oxytocin, an important neurohypophyseal neuropeptide in the central nervous system, has a wide range of behavioral effects, including regulating drug abuse. The present paper reviews the progress of research into the role of oxytocin in reducing psychostimulant-induced psychological dependence and the mechanisms by which oxytocin mediates its effects.
Introduction
Psychostimulants, also called psychoactive drugs, interfere with a variety of neurotransmitter systems, receptor families and signaling pathways to induce dependence, sensi tization, and withdrawal. Both the dopaminergic and the gluta minergic neurotransmitter systems have received considerable attention over the past few decades. For instance, the mesolimbic dopamine (DA) system, which originates in the ventral tegmental area, contributes at least partially to the reinforcing effects of many abused drugs [1] [2] [3] [4] [5] . In addition, the glutaminergic system, which has projections from the prefrontal cortex (PFC) to the ventral tegmental area (VTA) [6] , has also been shown to be involved in drug reward behaviors, such as conditioned place preference (CPP) [7] and behavioral sensitization (BS) [8] [9] [10] [11] . Oxytocin (OT), a neurohypophyseal neuropeptide that is synthesized and released from magnocellular neurosecretory cells of the paraventricular nucleus (PVN) and supraoptic nucleus (SON) in the hypothalamoneurohypophyseal system, has a wide range of behavioral effects in addition to its classical peripheral endocrine function. It has been demonstrated that OT can influence the development of tolerance to, dependence on, and reinstatement of abused drugs [12] [13] [14] [15] [16] [17] [18] . For instance, OT has been shown to inhibit tolerance and crosstolerance to some opioid substances [13] and to mitigate withdrawal symptoms. It has also been shown to block several addiction related behaviors induced by opioids or psychostimulants in rodents [14] [15] [16] [17] [18] . In addition to the research investigating the effects of OT on addictionrelated behaviors, other lines of research have focused on the neurochemical mechanisms by which OT modulates psychostimulantinduced behavioral effects [17] . The present paper reviews the inhibitory role of OT in psy chostimulant dependence and presents the current knowledge of its mechanism of action, including a review of two of the primary neuronal systems through which OT is thought to mediate its effects.
Effects of OT on behavioral changes induced by psychostimulants
Psychostimulant administration often induces marked behavioral changes, including hyperlocomotion and stereo typed behavior, among others. It has been reported that lateral ventricular injection of OT causes a dosedependent attenuation of cocaineinduced sniffing [19] and enhances cocaineinduced behavioral sensitization. In contrast, OT does not change the stereotyped behavior induced by methamphetamine (MAP) [20] . Intracerebroventricular admin [16] .
Effect of OT on psychostimulant-induced behavioral change in rodents By binding to OT receptors located in the limbicforebrain areas, OT significantly inhibits the hyperactivity induced by psychostimulants possibly through the mechanism associated with the dopaminergic system [17, 20, 21] . Furthermore, microinjection of OT into the central amygdala and the bed nucleus of the stria terminalis results in an inhibition of aggressive behavior in lactating female rats [22] . Results have shown that acute MAP administration significantly increases locomotor activity in mice, an effect that can be inhibited by intracerebroventricular administration of OT. Furthermore, atosiban (Ato), a specific blocker of OT receptor, markedly attenuates the inhibitory effect of OT on MAPinduced hyperactivity [17] . Repeated intermittent administration of psychostimulants causes an increase in their psychomotor stimulating effects and induces longterm hyperactivity [23, 24] . As shown in Table  1 , OT has multiple effects on behavioral changes induced by psychostimulants, such as behavioral sensitization, stereo typed behavior, and selfadministration (SA). Sarnyai et al have demonstrated that a subcutaneous injection of OT fol lowing cocaine administration increases cocaineinduced BS, whereas a prophylactic injection of OT inhibits the behavioral tolerance of rats to cocaine [20, 25] . Carson et al reported that OT dosedependently reduced MAP SA and almost completely blocked hyperactivity in response to MAP [26] . Taken together, these results suggest that OT can inhibit the behavioral changes induced by psychostimulants in rodents.
Effect of OT on MAP-induced conditioned place preference in mice The CPP paradigm, which contains several phases, including acquisition, expression, extinction and reinstatement of addic tion, is thought to provide a reliable indication of the reward ing properties of drugs in animals [27] . Moreover, the extinction preference for the drugpaired environment can be reinstated by either drug priming or stress [28] . Numerous studies have demonstrated that MAP reliably induces a CPP in mice. Our previous studies have shown that intracerebroventricular injections of OT significantly attenuate the acquisition of CPP induced by MAP and block the reinstatement of CPP induced by restraint stress. In contrast, neither CPP expression nor CPP reinstatement induced by priming with MAP is influ enced by OT [18] . Typically, MAPinduced CPP persists until at least the seventh day after the last drugpairing session, but OT shows an extinctionaccelerating effect on MAPinduced CPP, which can be attenuated significantly by Ato [18] . Taken together, these results indicate that OT exerts inhibitory effect on specific stages of MAP-induced CPP via the OT receptor.
Effect of OT on the CNS levels of DA and glutamate induced by psychostimulants
Recent studies have demonstrated that the synaptic plasticity of dopaminergic and glutaminergic neurons plays a key role in psychostimulant abuse and relapse [29, 30] . Lines of evidence showed that the suppressive effect of OT on psychostimulants induced behavioral changes [15] [16] [17] [18] . Therefore, it seems reason able that the inhibition of excessive release of glutamate (Glu) and DA by OT in relevant brain regions may contribute to the interruption of psychological dependence on psychostimu lants.
Effect of OT on the levels of DA and its metabolites in different brain regions
It is well established that the mesolimbic DA system, includ ing the VTA, plays an essential role in the reinforcing actions of many drugs (including MAP). An overwhelming body of evidence indicates that DA is partially responsible for the rein forcing effects of many abused drugs [5] . Several dopaminergic nuclei, particularly the nucleus accumbens (NAc), have been shown to be involved in psychostimulant reinforcement.
Over the last few decades, regulation of the pathophysi ological process of drug dependence by OT had been shown to be partially mediated by its effects on dopaminergic func tion. Furthermore, OT decreases DA release and DA receptor binding in the mesolimbic dopaminergic system [18] . Moreover, evidence suggests that concurrent activation of OT recep tors and DA D 2 type receptors in the NAc is essential for several functions to occur, which lead to various behavioral changes [31] . It has been reported that OT antagonizes the increased utilization rate of DA (measured by DOPAC/DA and HVA/DA) in the NAc elicited by cocaine, suggesting that OT is likely to influence the behavioral effects of cocaine by affecting dopaminergic neurotransmission [21] . OT is thought to act as a neuromodulator of dopaminergic neurotransmis sion in limbicbasal forebrain structures and thus regulate adaptive processes in CNS leading to drug addiction [12, 32] . Our studies have shown that OT prevents the behavioral effects of MAP, possibly through its attenuation of DA utilization in the striatum and NAc but not in the prefrontal cortex (PFC). The changes in DA turnover in the striatum and NAc induced by OT can be inhibited by Ato, suggesting that OT exerts its action through its receptor in striatum and NAc [17, 33] .
Effect of OT on glutamate levels in different brain regions Glutaminergic neurons and projections in the CNS have received considerable attention because of their involvement in drugrewardrelated behaviors, such as SA [34] and CPP [7] . Previous studies have demonstrated that the glutaminer gic system in the mPFC, hippocampus, striatum and NAc is involved in morphine dependence and withdrawal [35] . In addition, it has been shown that glutaminergic neurotrans mission in the VTA, PFC and NAc is necessary for cocaine induced reinstatement [36] [37] [38] [39] . Previous data have shown that OT inhibits Glu activation by binding to OT receptors in the spinal cord and that prior OT application blocks the increased neuronal firing rate produced by Glu in antinociceptive progress, indicating that Glu may also be related to the effect of OT on dependence induced by abused drugs [40] [41] [42] [43] . Our studies have shown that OT mark edly inhibits the incease of extracellular Glu levels induced by restraint stress in mice exhibiting CPP but not those induced by MAP priming, and the administration of Ato attenuates the effects of OT on the changes in Glu levels [18] . Therefore, these findings suggest that OT inhibits drug-reward-related behav iors induced by MAP via the OT receptor and that OT blocks the reinstatement of CPP, at least partially, by interfering with the glutaminergic system in the mPFC.
Effect of OT on NMDAR1 expression induced by psychostimulant drugs
Although a few studies have shown that OT is able to affect the binding of some neurotransmitters to their receptors [35] , little is known regarding OT's effect on neurotransmitter receptor expression. NMDA receptors are known to be involved in drug addiction. Our studies have demonstrated that the expression of the NMDAR1 subunit in PFC was increased by acute MAP and MAPchallenging relapse and decreased by MAP withdrawal, indicating that NMDA receptor function in PFC may be partially associated with MAPinduced neurobehavioral changes. No significant dif ference in NMDAR1 expression was observed in the hip pocampi of mice after treatment with MAP. Furthermore, each of these changes in NMDAR1 expression in the PFC could be significantly attenuated by OT [44] [45] [46] [47] . These findings indicate that OT attenuates the changes in glutaminergic neurotransmission induced by MAP, partially via its effect on NMDAR1. Whether these effects of OT on NMDAR1 expression are related to its inhibition of MAPinduced psychological dependence has not been determined.
Conclusion and prospects
In recent decades, increasing evidence has shown that OT plays an important role in psychostimulant dependence via its actions on OT receptors in several brain regions. Although the mechanisms underlying the effects of OT are not clear, it appears that the ability of OT to modulate MAP induced psychologically dependent behavior such as BS, CPP and SA, is closely related to its effects on dopaminergic neurotransmission in mesolimbic regions and its effects on glutaminergic neurotransmission in the forebrain.
Therefore, the present review suggests that OT might be a potential candidate for the prevention and treatment of neu rological disorders induced by psychostimulants. Further elucidating the mechanism of action of OT in regulating psychostimulant dependence may highlight its potential as a novel pharmacotherapy for drug craving.
